1. Home
  2. VTS vs CTMX Comparison

VTS vs CTMX Comparison

Compare VTS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vitesse Energy Inc.

VTS

Vitesse Energy Inc.

HOLD

Current Price

$17.97

Market Cap

733.0M

Sector

Energy

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$2.42

Market Cap

716.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTS
CTMX
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
733.0M
716.9M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
VTS
CTMX
Price
$17.97
$2.42
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
★ $21.50
$12.25
AVG Volume (30 Days)
375.2K
★ 2.9M
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 9.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $273,989,000.00
$76,201,000.00
Revenue This Year
$26.85
N/A
Revenue Next Year
N/A
$1.24
P/E Ratio
★ N/A
$22.58
Revenue Growth
★ 13.22
N/A
52 Week Low
$15.00
$2.20
52 Week High
$22.91
$8.21

Technical Indicators

Market Signals
Indicator
VTS
CTMX
Relative Strength Index (RSI) 59.31 41.37
Support Level $17.33 $2.20
Resistance Level $18.61 $3.93
Average True Range (ATR) 0.38 0.15
MACD 0.11 0.02
Stochastic Oscillator 69.52 45.74

Price Performance

Historical Comparison
VTS
CTMX

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana with limited operations. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: